Osaic Holdings’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,761
Closed -$3.66K 8045
2025
Q3
$3.66K Buy
1,761
+401
+29% +$862 ﹤0.01% 6913
2025
Q2
$3.36K Sell
1,360
-4
-0.3% -$9 ﹤0.01% 6749
2025
Q1
$1.72K Sell
1,364
-2,560
-65% -$9.33K ﹤0.01% 6657
2024
Q4
$12.6K Hold
3,924
﹤0.01% 5633
2024
Q3
$12.3K Hold
3,924
﹤0.01% 5683
2024
Q2
$12.3K Sell
3,924
-2,115
-35% -$7.8K ﹤0.01% 5652
2024
Q1
$29.5K Sell
6,039
-68
-1% -$330 ﹤0.01% 5109
2023
Q4
$36.1K Buy
+6,107
New +$24.6K ﹤0.01% 5109

Osaic Holdings's MURA Position: Q4 2025 in Review

Osaic Holdings sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1,761 shares — an estimated $3.66K sold.

Osaic Holdings first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $36.1K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • Osaic Holdings reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 1,761 Mural Oncology shares in Q4 2025, an estimated $3.66K.
  • Osaic Holdings first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
  • Osaic Holdings's Mural Oncology position peaked at $36.1K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.